...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.
【24h】

Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.

机译:Sigma-1配体:Tic-乙内酰脲为主要药效团。

获取原文
获取原文并翻译 | 示例
           

摘要

Sigma-1 receptors are involved in numerous pathological dysfunctions and the synthesis of selective ligands is of interest. We identified a fused tetrahydroisoquinoline-hydantoin (Tic-hydantoin) structure with high affinity and selectivity for these receptors. We report here our efforts towards the pharmacomodulation of this substructure, the synthesis of 9 analogs with stereochemistry inversion, opening of isoquinoline ring, removal of isoquinoline nitrogen, replacement of isoquinoline by pyridine, of Tic-hydantoin moiety by quinazolinedione heterocycle. All these analogs provided a loss in the affinity for the sigma-1 receptor. The present work underlines the real importance of the Tic-hydantoin moiety for the obtainment of high affinity ligands.
机译:Sigma-1受体与许多病理功能障碍有关,选择性配体的合成受到关注。我们确定了对这些受体具有高亲和力和选择性的融合四氢异喹啉-乙内酰脲(Tic-乙内酰脲)结构。我们在这里报告了我们对该亚结构的药代动力学的努力,合成了9个具有立体化学反转的类似物,打开了异喹啉环,除去了异喹啉氮,用吡啶取代了异喹啉,用喹唑啉二酮杂环取代了Tic-乙内酰脲部分。所有这些类似物都丧失了对sigma-1受体的亲和力。本工作强调了Tic-乙内酰脲部分对于获得高亲和力配体的真正重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号